COMPUGEN LTD. (CGEN)
Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
Lightbridge Participates in Launch of UPRISE Nuclear Power Uprate Event at the White House
Ambow Education Holding Ltd. (NYSE American: AMBO) Launches HybriU ProjectHub, an AI-Powered Project Collaboration Platform Unifying Documents, Conversations, and Live Collaboration in a Single Secure Workspace
CervoMed Secures New U.S. Patent Protecting Use of Neflamapimod in Pure Dementia with Lewy Body Patients into 2042
Enanta Pharmaceuticals Announces Advancement of its Zelicapavir Clinical Development Program for the Treatment of Respiratory Syncytial Virus (RSV)
Oklo, Centrus Sign Letter of Intent to Purchase Nuclear Fuel for Aurora Powerhouse Deployment in Southern Ohio
Veteran Investor and Widely Followed Market Analyst Shah Gilani Calls VENU Stock “Significantly Undervalued”
MarketAxess Introduces TraX Tape, Delivering an Enriched View of Bond Market Activity
Nuvini Launches Second AI Prize, Targeting 100% Employee AI Adoption
Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress